Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Operating Income 2006-2019 | GILD

Gilead Sciences annual/quarterly operating income history and growth rate from 2006 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Gilead Sciences operating income for the quarter ending September 30, 2019 was $-1.473B, a 156.16% decline year-over-year.
  • Gilead Sciences operating income for the twelve months ending September 30, 2019 was $4.338B, a 53.59% decline year-over-year.
  • Gilead Sciences annual operating income for 2018 was $8.2B, a 41.94% decline from 2017.
  • Gilead Sciences annual operating income for 2017 was $14.124B, a 19.9% decline from 2016.
  • Gilead Sciences annual operating income for 2016 was $17.633B, a 20.55% decline from 2015.
  
Gilead Sciences Annual Operating Income
(Millions of US $)
2018 $8,200
2017 $14,124
2016 $17,633
2015 $22,193
2014 $15,265
2013 $4,524
2012 $4,010
2011 $3,790
2010 $3,962
2009 $3,529
2008 $2,679
2007 $2,165
2006 $-759
2005 $1,109
Gilead Sciences Quarterly Operating Income
(Millions of US $)
Q3 2019 $-1,473
Q2 2019 $2,430
Q1 2019 $2,237
Q4 2018 $1,144
Q3 2018 $2,623
Q2 2018 $2,280
Q1 2018 $2,153
Q4 2017 $2,291
Q3 2017 $3,812
Q2 2017 $4,254
Q1 2017 $3,767
Q4 2016 $4,045
Q3 2016 $4,399
Q2 2016 $4,538
Q1 2016 $4,651
Q4 2015 $5,621
Q3 2015 $5,585
Q2 2015 $5,616
Q1 2015 $5,371
Q4 2014 $4,330
Q3 2014 $3,480
Q2 2014 $4,412
Q1 2014 $3,043
Q4 2013 $1,197
Q3 2013 $1,148
Q2 2013 $1,154
Q1 2013 $1,025
Q4 2012 $1,107
Q3 2012 $1,044
Q2 2012 $1,059
Q1 2012 $800
Q4 2011 $867
Q3 2011 $1,004
Q2 2011 $1,017
Q1 2011 $902
Q4 2010 $829
Q3 2010 $979
Q2 2010 $993
Q1 2010 $1,161
Q4 2009 $1,065
Q3 2009 $894
Q2 2009 $761
Q1 2009 $808
Q4 2008 $711
Q3 2008 $694
Q2 2008 $606
Q1 2008 $668
Q4 2007 $514
Q3 2007 $547
Q2 2007 $543
Q1 2007 $560
Q4 2006 $-1,553
Q3 2006 $58
Q2 2006 $365
Q1 2006 $372
Q4 2005 $360
Q3 2005 $248
Q2 2005 $277
Q1 2005 $223
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $84.866B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.902B 16.00
CSL (CSLLY) Australia $87.394B 0.00
Vertex Pharmaceuticals (VRTX) United States $57.409B 58.60
Biogen (BIIB) United States $54.179B 9.30
Illumina (ILMN) United States $47.991B 52.66
Regeneron Pharmaceuticals (REGN) United States $40.872B 17.90
Alexion Pharmaceuticals (ALXN) United States $25.203B 12.45
Incyte (INCY) United States $20.351B 47.24
Seattle Genetics (SGEN) United States $20.138B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.356B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.798B 0.00
Galapagos (GLPG) Belgium $11.704B 30.16
Exact Sciences (EXAS) United States $11.197B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.429B 30.74
BeiGene (BGNE) Cayman Islands $8.976B 0.00
Bio-Techne Corp (TECH) United States $8.358B 55.95
Sarepta Therapeutics (SRPT) United States $8.159B 0.00
Amarin (AMRN) Ireland $8.019B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.917B 0.00
Guardant Health (GH) United States $6.947B 0.00
Medicines (MDCO) United States $6.714B 0.00
Moderna (MRNA) United States $6.312B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.037B 15.35
Reata Pharmaceuticals (RETA) United States $6.034B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.618B 0.00
BioNTech SE (BNTX) Germany $5.514B 0.00
Exelixis (EXEL) United States $5.275B 14.84
Repligen (RGEN) United States $4.701B 85.19
China Biologic Products (CBPO) China $4.603B 25.93
Ascendis Pharma (ASND) Denmark $4.532B 0.00
Bluebird Bio (BLUE) United States $4.394B 0.00
Spark Therapeutics (ONCE) United States $4.263B 0.00
MorphoSys AG (MOR) Germany $4.153B 0.00
Mirati Therapeutics (MRTX) United States $4.047B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.995B 0.00
Immunomedics (IMMU) United States $3.981B 0.00
Blueprint Medicines (BPMC) United States $3.861B 0.00
Adaptive Biotechnologies (ADPT) United States $3.613B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.518B 0.00
Alkermes (ALKS) Ireland $3.300B 0.00
MyoKardia (MYOK) United States $3.117B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
UniQure (QURE) Netherlands $2.881B 0.00
Emergent Biosolutions (EBS) United States $2.838B 28.19
Halozyme Therapeutics (HALO) United States $2.808B 0.00
NeoGenomics (NEO) United States $2.779B 147.89
Acceleron Pharma (XLRN) United States $2.648B 0.00
Amicus Therapeutics (FOLD) United States $2.576B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.484B 0.00
Arena Pharmaceuticals (ARNA) United States $2.408B 5.60
Zai Lab (ZLAB) China $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Insmed (INSM) United States $2.064B 0.00
Myriad Genetics (MYGN) United States $1.905B 28.14
Ligand Pharmaceuticals (LGND) United States $1.897B 36.49
Dicerna Pharmaceuticals (DRNA) United States $1.822B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.782B 0.00
Denali Therapeutics (DNLI) United States $1.754B 0.00
Epizyme (EPZM) United States $1.659B 0.00
Akcea Therapeutics (AKCA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
REGENXBIO (RGNX) United States $1.647B 0.00
Editas Medicine (EDIT) United States $1.586B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.402B 0.00
Athenex (ATNX) United States $1.376B 0.00
Alector (ALEC) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.352B 0.00
Innoviva (INVA) United States $1.308B 3.85
Arvinas (ARVN) United States $1.297B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Principia Biopharma (PRNB) United States $1.226B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.151B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.109B 0.00
Zealand Pharma (ZEAL) Denmark $1.046B 0.00
Fate Therapeutics (FATE) United States $1.033B 0.00
Precision BioSciences (DTIL) United States $0.998B 0.00
Pharming Group (PHGUF) Netherlands $0.968B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.934B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.932B 7.83
Codexis (CDXS) United States $0.909B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 310.50
MiMedx (MDXG) United States $0.821B 0.00
Anika Therapeutics (ANIK) United States $0.820B 26.61
Twist Bioscience (TWST) United States $0.813B 0.00
Heska (HSKA) United States $0.749B 191.46
Adverum Biotechnologies (ADVM) United States $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.718B 12.25
DBV Technologies S.A (DBVT) France $0.717B 0.00
UROGEN PHARMA (URGN) United States $0.685B 0.00
Cara Therapeutics (CARA) United States $0.671B 0.00
Mesoblast (MESO) Australia $0.665B 0.00
Cellectis S.A (CLLS) France $0.623B 0.00
GENFIT S.A (GNFT) France $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.593B 13.72
Autolus Therapeutics (AUTL) United Kingdom $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Kadmon Holdings (KDMN) United States $0.584B 0.00
Sorrento Therapeutics (SRNE) United States $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.576B 0.00
PHARMA MAR SA (PHMMF) Spain $0.570B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.564B 0.00
Cytokineticsorporated (CYTK) United States $0.557B 0.00
Agenus (AGEN) United States $0.537B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.518B 3.58
Stemline Therapeutics (STML) United States $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Bellus Health (BLU) Canada $0.402B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.337B 8.43
Pfenex (PFNX) United States $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.325B 0.00
Starpharma Holdings (SPHRY) Australia $0.320B 0.00
Puma Biotechnology (PBYI) United States $0.307B 0.00
Kindred Biosciences (KIN) United States $0.303B 0.00
Geron (GERN) United States $0.302B 0.00
Kamada (KMDA) Israel $0.297B 8.67
CytomX Therapeutics (CTMX) United States $0.286B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Cel-Sci (CVM) United States $0.273B 0.00
Cue Biopharma (CUE) United States $0.269B 0.00
Albireo Pharma (ALBO) United States $0.264B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Scholar Rock Holding (SRRK) United States $0.252B 0.00
MannKind (MNKD) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.228B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
XOMA (XOMA) United States $0.223B 0.00
Theratechnologies (THTX) Canada $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
Protagonist Therapeutics (PTGX) United States $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Senesco Technologies (ELOX) United States $0.205B 0.00
Mersana Therapeutics (MRSN) United States $0.203B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
IVERIC Bio (ISEE) United States $0.183B 0.00
Palatin Technologies (PTN) United States $0.182B 4.96
Proteostasis Therapeutics (PTI) United States $0.182B 0.00
Cerecor (CERC) United States $0.176B 0.00
Affimed (AFMD) Germany $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Alcobra (ARCT) United States $0.162B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.156B 0.00
NantKwest (NK) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.149B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Fortress Biotech (FBIO) United States $0.141B 0.00
Aptinyx (APTX) United States $0.139B 0.00
TELA Bio (TELA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Arbutus Biopharma (ABUS) Canada $0.130B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nicox SA (NICXF) France $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.117B 0.00
BioTime (LCTX) United States $0.117B 6.01
Novavax (NVAX) United States $0.116B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.098B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.092B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Orgenesis (ORGS) United States $0.044B 2.83
Celldex Therapeutics (CLDX) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Apricus Biosciences (SEEL) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Signal Genetics (MGEN) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00